Tag: CRO
Veeda Clinical Research acquires European CRO ‘Heads’
With this acquisition, Veeda’s global pharmaceutical and biotech clients can now leverage the unique and unparalleled suite of early to late-phase CRO services across Europe, US, and Asia Pacific
Parexel named ‘Best Contract Research Organization’ at 19th Annual Scrip Awards
The company recognized with prestigious industry award by a distinguished panel of life science industry executives
Emmes appoints Peter Ronco as CEO
Peter Ronco succeeds Dr Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri, and Emmes’ Board of Directors
India’s promising CRO story
Post pandemic, Indian Contract Research Organizations have re-engineered their resources to tap the increasing demand from North America and Europe, writes Dr Kiran Marthak
Parexel rated top CRO to work with
Company receives highest average rating across all 26 performance attributes out of 34 CROs included in survey and highest net promoter score demonstrating likelihood to be recommended to colleagues
Parexel launches ‘New Medicines, Novel Insights’ expert series
New evidence-based reports offer timely analysis and actionable guidance to drug developers bringing critical new therapies to market
Parexel teams with MyEyeDr. to increase patient access & participation in...
New collaboration leverages MyEyeDr.’s 850+ offices across the US to refer patients into ophthalmology and other therapeutic area clinical trials, expands Parexel’s Community Alliance Network to bring trials to patients where they are
MedGenome & Emmes launch genomics strategic partnership focused on advancing rare...
The two companies have partnered to support the advancement of public health and biopharmaceutical innovation, aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients
“Over 200 active clinical studies underway in India”
This edition of 'Face to Face' features Dr Sanish Davis, President, Indian Society for Clinical Research (ISCR) who shares his expert views on learnings from ongoing pandemic, current clinical research scenario, policy, challenges, opportunities and future outlook...................
Veeda Clinical Research acquires majority stake in Bioneeds
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on................